Article Submission Guidelines - BiopharmaDirect

Article Submission Guidelines

Authors are encouraged to share their thoughts and insights about science and technology with BiopharmaDirect’s readers. Articles that are insightful and inspiring will be published rapidly as soon as they are accepted, after passing a series of prepublication checks to assess originality, readability, author eligibility, and compliance with our policies and ethical guidelines.

Instructions for Article Submission

Please adhere to the following guidelines when submitting an article for publication:

Originality: Articles submitted must be written exclusively for BiopharmaDirect, and must not have been previously published or submitted to any other publisher.

Promotion: Articles must not be commercial or promotional with respect to any specific product or service. Any such references will be omitted or reworded in general terms. No more than 2 promotional anchor text links are allowed in each article.

Topic: Topics related to the research and development of small molecules, macromolecules, and nucleic acid drugs are welcomed. To name just a few here, cutting-edge technologies, research hotspots, latest achievements, drug research and development technology methods, pioneering company news, industry development trends, etc.

Length: Ideally 800-1,000 words in length, not counting notes, tables, and charts.

Format: Articles can be submitted as Word (DOC or DOCX) or rich text format (RTF) files only, we do not accept PDF, ZIP or TeX files.

• Articles should be written in English and are clearly organized (best with headings and subtitles), fluent, and neutral.
• It is recommended to use high-resolution pictures.
• Please also indicate the source of the quoted pictures or literature.
• An abstract of no more than 150 words is required.

Relevant information about the author should be listed and sent along with the article, including authors' names, positions, institutions, mailing and e-mail addresses.